OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Incretins beyond type 2 diabetes
Chantal Mathieu, Iraj Ahmadzai
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1809-1819
Closed Access | Times Cited: 8
Chantal Mathieu, Iraj Ahmadzai
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1809-1819
Closed Access | Times Cited: 8
Showing 8 citing articles:
Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity
Daniel J. Drucker
Diabetes Care (2024)
Open Access | Times Cited: 83
Daniel J. Drucker
Diabetes Care (2024)
Open Access | Times Cited: 83
Novel pharmacotherapies for weight loss: Understanding the role of incretins to enable weight loss and improved health outcomes
Thomas Först, Christophe De Block, Stefano Del Prato, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Thomas Först, Christophe De Block, Stefano Del Prato, et al.
Diabetes Obesity and Metabolism (2025)
Closed Access
Metabolic health in people living with type 1 diabetes in Belgium: a repeated cross-sectional study
Astrid Lavens, Christophe De Block, Philippe Oriot, et al.
Diabetologia (2024)
Open Access | Times Cited: 3
Astrid Lavens, Christophe De Block, Philippe Oriot, et al.
Diabetologia (2024)
Open Access | Times Cited: 3
Consensus Report on Glucagon-Like Peptide-1 Receptor Agonists as Adjunctive Treatment for Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System
Viral N. Shah, Anne L. Peters, Guillermo E. Umpierrez, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 3
Viral N. Shah, Anne L. Peters, Guillermo E. Umpierrez, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 3
Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity
Špela Volčanšek, Andrijana Koceva, Mojca Jensterle, et al.
Diabetes Therapy (2025)
Open Access
Špela Volčanšek, Andrijana Koceva, Mojca Jensterle, et al.
Diabetes Therapy (2025)
Open Access
<p>Early effects of roflumilast on insulin sensitivity in adults with prediabetes and overweight/obesity involve age-associated fat mass loss – results of an exploratory study</p>
Ijeoma Muo, Sandra D. MacDonald, Ritu Madan, et al.
Diabetes Metabolic Syndrome and Obesity (2019) Vol. Volume 12, pp. 743-759
Open Access | Times Cited: 16
Ijeoma Muo, Sandra D. MacDonald, Ritu Madan, et al.
Diabetes Metabolic Syndrome and Obesity (2019) Vol. Volume 12, pp. 743-759
Open Access | Times Cited: 16
GLP-1 Receptor Agonists in Overweight and Obese Individuals With Type 1 Diabetes Using an Automated Insulin Delivery Device: A Real-World Study
Pernille Holmager, Merete B. Christensen, Kirsten Nørgaard, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 1
Pernille Holmager, Merete B. Christensen, Kirsten Nørgaard, et al.
Journal of Diabetes Science and Technology (2024)
Closed Access | Times Cited: 1
Incretins: turning the venom into the antidote
Anna Krook, Hindrik Mulder
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1762-1764
Open Access | Times Cited: 1
Anna Krook, Hindrik Mulder
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1762-1764
Open Access | Times Cited: 1
Outcomes of Type 2 Diabetes Management: One Center Experience 2015–2023
Rudolf Chlup, Hana Zálešáková, Jiřina Gottwaldová, et al.
IntechOpen eBooks (2024)
Open Access
Rudolf Chlup, Hana Zálešáková, Jiřina Gottwaldová, et al.
IntechOpen eBooks (2024)
Open Access
